Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 11
Submit an article Journal homepage
593
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*

Helmut Minne Klinik ‘Der Fürstenhof’, Bad Pyrmont, Germany
,
Maurice Audran Centre Hospitalier Universitaire, Angers, France
,
Maria E. Simões Instituto Portugues de Reumatologia, Lisbon, Portugal
,
Barbara Obermayer-Pietsch Universitätsklinik für Innere Medizin, Medizinische Universität, Graz, Austria
,
Gunnar Sigurðsson Department of Endocrinology and Metabolism, Landspítali – University Hospital, Reykjavik, Iceland
,
Fernando Marín Department of Medical Research, Lilly Research Center, Windlesham, United Kingdom
,
Gail P. Dalsky Department of Medical Research, Lilly Research Center, Windlesham, United Kingdom
,
Thomas Nickelsen Department of Medical Research, Lilly Research Center, Windlesham, United KingdomCorrespondence[email protected]
& for the EUROFORS Study Groupf show all
Pages 3117-3128 | Accepted 10 Sep 2008, Published online: 06 Oct 2008

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Michael R. McClung, Micol S. Rothman, E. Michael Lewiecki, David A. Hanley, Steven T. Harris, Paul D. Miller & David L. Kendler. (2022) The role of osteoanabolic agents in the management of patients with osteoporosis. Postgraduate Medicine 134:6, pages 541-551.
Read now
Athanasios D. Anastasilakis, Stergios A. Polyzos, Maria P. Yavropoulou & Polyzois Makras. (2020) Combination and sequential treatment in women with postmenopausal osteoporosis. Expert Opinion on Pharmacotherapy 21:4, pages 477-490.
Read now
Mikio Kamimura, Akira Taguchi, Yukio Nakamura, Hidefumi Koiwai, Shota Ikegami, Shigeharu Uchiyama & Hiroyuki Kato. (2018) Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy. Therapeutics and Clinical Risk Management 14, pages 637-642.
Read now
S. Palacios & A. Mejía. (2015) Antiresorptives and anabolic therapy in sequence or combination for postmenopausal osteoporosis. Climacteric 18:4, pages 453-455.
Read now
George Lyritis, Fernando Marin, Clare Barker, Michael Pfeifer, Jordi Farrerons, Kim Brixen, Javier del Pino, Richard Keen & Thomas N. Nickelsen. (2010) Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Current Medical Research and Opinion 26:8, pages 1799-1807.
Read now

Articles from other publishers (17)

Sharon Giveon, Galia Zacay, Iris Vered, A. Joseph Foldes & Liana Tripto-Shkolnik. (2023) Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone. Therapeutic Advances in Endocrinology and Metabolism 14.
Crossref
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management 617 644 .
Sven Oser & Hans Jörg Häuselmann. (2021) Verschiedene Perspektiven von Therapiepausen und Kombinations-therapien bei Osteoporose. Praxis 110:16, pages 975-983.
Crossref
Michael R. McClung. (2021) Role of bone-forming agents in the management of osteoporosis. Aging Clinical and Experimental Research 33:4, pages 775-791.
Crossref
Athanasios D Anastasilakis, Stergios A Polyzos & Polyzois Makras. (2018) THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis. European Journal of Endocrinology 179:1, pages R31-R45.
Crossref
Liron Caplan, Karen E. Hansen & Kenneth G. Saag. (2017) Editorial: Response to the American College of Physicians Osteoporosis Guideline, 2017 Update. Arthritis & Rheumatology 69:11, pages 2097-2101.
Crossref
R. Niimi, T. Kono, A. Nishihara, M. Hasegawa, T. Kono & A. Sudo. (2016) A retrospective analysis of nonresponse to daily teriparatide treatment. Osteoporosis International 27:9, pages 2845-2853.
Crossref
R. Lindsay, J. H. Krege, F. Marin, L. Jin & J. J. Stepan. (2016) Teriparatide for osteoporosis: importance of the full course. Osteoporosis International 27:8, pages 2395-2410.
Crossref
Mikio Kamimura, Yukio Nakamura, Shota Ikegami, Shigeharu Uchiyama & Hiroyuki Kato. (2016) Bisphosphonate Pre-Treatment Diminishes the Therapeutic Benefits of Teriparatide in Japanese Osteoporotic Patients. The Tohoku Journal of Experimental Medicine 239:1, pages 17-24.
Crossref
S. Ishtiaq, I. Fogelman & G. Hampson. (2014) Treatment of post-menopausal osteoporosis: beyond bisphosphonates. Journal of Endocrinological Investigation 38:1, pages 13-29.
Crossref
Lucas R Brun, Ana M Galich, Eduardo Vega, Helena Salerni, Laura Maffei, Valeria Premrou, Pablo R Costanzo, Marcelo A Sarli, Paula Rey, María S Larroudé, María S Moggia, María L Brance & Ariel Sánchez. (2014) Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment. SpringerPlus 3:1.
Crossref
Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher & John H. Krege. (2014) Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis. Bone 67, pages 246-256.
Crossref
Ailsa J. Oswald, Jackie Berg, Garry Milne & Stuart H. Ralston. (2013) Teriparatide Treatment of Severe Osteoporosis Reduces the Risk of Vertebral Fractures Compared with Standard Care in Routine Clinical Practice. Calcified Tissue International 94:2, pages 176-182.
Crossref
P. Hadji, J. R. Zanchetta, L. Russo, C. P. Recknor, K. G. Saag, F. E. McKiernan, S. L. Silverman, J. Alam, R. T. Burge, J. H. Krege, M. C. Lakshmanan, D. N. Masica, B. H. Mitlak & J. L. Stock. (2011) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International 23:8, pages 2141-2150.
Crossref
Charles A. InderjeethKien ChanPaul Glendenning. (2011) Teriparatide: Its Use in the Treatment of Osteoporosis. Clinical Medicine Insights: Therapeutics 3, pages CMT.S2358.
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:6, pages 470-480.
Crossref
Brian J. Gates, Travis E. Sonnett, Cristina A.K. DuVall & Erin K. Dobbins. (2009) Review of osteoporosis pharmacotherapy for geriatric patients. The American Journal of Geriatric Pharmacotherapy 7:6, pages 293-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.